Add to ORKGOncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mic
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Radioresistance is one of the main determinants of treatment outcome in oral squamous cell carcinoma...
The therapeutic utility of oncolytic adenoviruses controlled by a single, tumor-specific regulatory ...
Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral ...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Adenoviruses (Ads) with deletion of E1b55K preferentially replicate in cancer cells and have been us...
Breast cancer is the most diagnosed cancer in women under 60 and the second most diagnosed cancer in...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for...
Neuroendocrine tumors (NETs), originally described as carcinoids, represent a rare and heterogeneous...
Cyclin E, a regulatory subunit of cyclin-dependent kinase 2 (CDK2), is central to the initiation of ...
Virotherapy of cancer using oncolytic adenoviruses has shown promise in both preclinical and clinica...
Checkpoint inhibitors have revolutionized cancer therapy and validated immunotherapy as an approach....
Immunotherapy has moved to the forefront of modern oncologic treatment in the past few decades. Vari...
Oncolytic adenovirus (Ad) has been used in cancer gene therapy largely due to its ability to selecti...
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Radioresistance is one of the main determinants of treatment outcome in oral squamous cell carcinoma...
The therapeutic utility of oncolytic adenoviruses controlled by a single, tumor-specific regulatory ...
Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral ...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
Adenoviruses (Ads) with deletion of E1b55K preferentially replicate in cancer cells and have been us...
Breast cancer is the most diagnosed cancer in women under 60 and the second most diagnosed cancer in...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for...
Neuroendocrine tumors (NETs), originally described as carcinoids, represent a rare and heterogeneous...
Cyclin E, a regulatory subunit of cyclin-dependent kinase 2 (CDK2), is central to the initiation of ...
Virotherapy of cancer using oncolytic adenoviruses has shown promise in both preclinical and clinica...
Checkpoint inhibitors have revolutionized cancer therapy and validated immunotherapy as an approach....
Immunotherapy has moved to the forefront of modern oncologic treatment in the past few decades. Vari...
Oncolytic adenovirus (Ad) has been used in cancer gene therapy largely due to its ability to selecti...
Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for ...
Radioresistance is one of the main determinants of treatment outcome in oral squamous cell carcinoma...
The therapeutic utility of oncolytic adenoviruses controlled by a single, tumor-specific regulatory ...